Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Accept all cookies Reject all non-essential cookies Find out more

Centre for Tropical Medicine and Global Health nominated for MRS prize

CTMGH have been nominated for the Market Research Society President's Medal, awarded annually to an organisation that conduct extraordinary research but who might not be recognised through the usual channels. Our Centre is noted for its ingenious use of freely available online satellite images to gath data on the use of antibiotics in unmapped and inaccessible villages in rural Thailand and Laos. Researchers use the images to identify representative clusters of potential participants.

Satellite image of a rural village with the houses numbered © Source: Bing Maps

The full story is available on the MRS website

Similar stories

Salum Mshamu named a 2026 TIME Trailblazer

Congratulations to Salum Mshamu on being selected as one of TIME’s inaugural 2026 Trailblazers: Designing and Making the Future. A University of Oxford DPhil student, Salum was recognised for his contribution to research showing how improved housing design can reduce malaria and other childhood illnesses.

Oxford, WHO and partners announce next-generation AI initiative to detect, assess and respond to pandemics

The University of Oxford has been awarded €8 million through the European Union’s Horizon Europe programme to coordinate the development of the Pandemics AI Observatory (PANDAI). Led by the University in partnership with the World Health Organization and an international consortium of leading research, public health and technology partners, the three-year project will develop and deploy advanced artificial intelligence (AI) models to transform the detection, assessment, prediction and response to global infectious disease threats.

Behind the Title: Becoming an Oxford Professor (at NDM): Featuring Professor Direk Limmathurotsakul

The Behind the Title: Becoming an Oxford Professor (at NDM) series highlights the diverse journeys of our professors and the many paths that lead to academic leadership. By sharing their journeys we aim to showcase the breadth of backgrounds, disciplines, and experiences represented across the Department, demonstrating that there is no single route to becoming a professor at Oxford.

MODRA Cohort 1: Where they are now and what comes next?

Eighteen months after joining MODRA, our first fellows are leading projects, winning grants, and building new collaborations across the region. Upon completion of the MODRA programme and moving move into the next stage of their careers, here’s a look at how our fellows are turning learning into lasting impact.

Medicine Quality Research Group awarded £3.7 million to evaluate devices for detecting substandard and falsified vaccines

The Medical Research Council (UK) has awarded a £ 3.7 million DPFS grant to expand the work led by the Medicine Quality Research Group on innovative screening devices for detecting degraded and falsified vaccines.

Professor Direk Limmathurotsakul awarded 2026 UNESCO-Carlos J. Finlay Prize for Microbiology

Professor Direk Limmathurotsakul has received the 2026 UNESCO-Carlos J. Finlay Prize for Microbiology. The Prize recognises his contributions to microbiology, particularly his work on melioidosis, antimicrobial-resistant (AMR) infections and turning local data into public health action.

Similar stories

Salum Mshamu named a 2026 TIME Trailblazer

Congratulations to Salum Mshamu on being selected as one of TIME’s inaugural 2026 Trailblazers: Designing and Making the Future. A University of Oxford DPhil student, Salum was recognised for his contribution to research showing how improved housing design can reduce malaria and other childhood illnesses.

Oxford, WHO and partners announce next-generation AI initiative to detect, assess and respond to pandemics

The University of Oxford has been awarded €8 million through the European Union’s Horizon Europe programme to coordinate the development of the Pandemics AI Observatory (PANDAI). Led by the University in partnership with the World Health Organization and an international consortium of leading research, public health and technology partners, the three-year project will develop and deploy advanced artificial intelligence (AI) models to transform the detection, assessment, prediction and response to global infectious disease threats.

Behind the Title: Becoming an Oxford Professor (at NDM): Featuring Professor Direk Limmathurotsakul

The Behind the Title: Becoming an Oxford Professor (at NDM) series highlights the diverse journeys of our professors and the many paths that lead to academic leadership. By sharing their journeys we aim to showcase the breadth of backgrounds, disciplines, and experiences represented across the Department, demonstrating that there is no single route to becoming a professor at Oxford.

MODRA Cohort 1: Where they are now and what comes next?

Eighteen months after joining MODRA, our first fellows are leading projects, winning grants, and building new collaborations across the region. Upon completion of the MODRA programme and moving move into the next stage of their careers, here’s a look at how our fellows are turning learning into lasting impact.

Medicine Quality Research Group awarded £3.7 million to evaluate devices for detecting substandard and falsified vaccines

The Medical Research Council (UK) has awarded a £ 3.7 million DPFS grant to expand the work led by the Medicine Quality Research Group on innovative screening devices for detecting degraded and falsified vaccines.

Professor Direk Limmathurotsakul awarded 2026 UNESCO-Carlos J. Finlay Prize for Microbiology

Professor Direk Limmathurotsakul has received the 2026 UNESCO-Carlos J. Finlay Prize for Microbiology. The Prize recognises his contributions to microbiology, particularly his work on melioidosis, antimicrobial-resistant (AMR) infections and turning local data into public health action.